C16 - Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study

Autor: Cazzaniga, M., Orlando, L., Melegari, E., Arcangeli, V., Butera, A., Pinotti, G., Vallini, I., Mocerino, C., Giovanardi, F., Cretella, E., Gambaro, A., Pistelli, M., Donati, S., Pizzuti, L., Spagnuolo, A., Putzu, C., Leonardi, V., De Angelis, C., Pedroli, S., Torri, V.
Zdroj: In Annals of Oncology October 2017 28 Supplement 6:vi29-vi29
Databáze: ScienceDirect